Coherent (COHR) Stock Price Today
AlphaPepe crypto presale raises $3.1M with 12,600+ holders; new exchange partnership, possibly Binance, expected soon.
AlphaPepe's crypto presale has raised over $3.1 million with more than 12,600 holders, showing strong retail demand before its public exchange debut. The project features a live AI-powered DEX called AlphaSwap and is led by an ex-Shibarium developer,...
iCAUR debuts V25 and showcases customization at 2026 International User Summit in Wuhu, expanding global reach.
The 2026 iCAUR International User Summit in Wuhu, China, introduced the new iCAUR V25, expanding the V-Series lineup alongside the V23 and V27. The event highlighted the brand's Future Classic Design philosophy, vehicle customization, and user co-cre...
Monolithic Power Systems upgraded to Buy with $1,686 target after strong H1 revenue growth led by Enterprise Data.
Monolithic Power Systems received a Buy upgrade with a new price target of $1,686 due to strong first-half 2026 revenue growth of 37.1%, driven mainly by the Enterprise Data and Communications segments. Enterprise Data surged 132.4%, prompting manage...
Fitch affirms Ecopetrol's BB credit rating with stable outlook, citing strong financials and liquidity.
Fitch Ratings has affirmed Ecopetrol's global credit rating at BB with a stable outlook, highlighting the company's robust financial profile, strong liquidity, and stable operating metrics. The standalone credit profile remains investment grade at bb...
Enova withdraws bank acquisition applications, shares plunge 23% amid regulatory concerns
Enova International announced it has withdrawn its applications to acquire Grasshopper Bancorp due to unclear regulatory standards for nonbank entities seeking bank status. This unexpected move caused Enova's stock to drop 23.4% on heavy trading volu...
Actinogen Medical locks XanaMIA trial data, results due mid-November for Alzheimer's drug Xanamem
Actinogen Medical has entered 'database lock' for its XanaMIA Alzheimer's trial, finalizing data collection from 247 patients to analyze the effects of its drug Xanamem. The 36-week trial tested Xanamem's ability to slow Alzheimer's progression by co...
Onto Innovation shows growth potential despite recent selloff, driven by strong tech and order momentum.
Onto Innovation, a semiconductor company, is positioned for medium-term growth despite a recent selloff driven by market momentum. Its strengths lie in its metrology portfolio, advanced packaging, and a new x-ray technology partnership, which are hel...
Two cash-focused ETFs differ: SPHD targets dividends, COWZ targets free cash flow for returns.
Two popular ETFs, SPHD and COWZ, focus on cash but measure it differently: SPHD targets companies with high dividend payouts, providing monthly income for investors, while COWZ screens for companies with high free cash flow, emphasizing total return ...
Law firm investigates Xenon Pharmaceuticals after stock drops 31% on clinical trial pause
Wolf Popper LLP is investigating potential claims for investors who purchased Xenon Pharmaceuticals stock after the company paused new patient enrollment in its clinical trials for neurological and psychiatric drugs. The pause followed reports of neu...
Bitcoin rebounds near $83,000 as BlackRock leads biggest ETF inflow in a month.
Bitcoin has risen to around $83,000, supported by renewed institutional buying, particularly from BlackRock's iShares Bitcoin Trust, which saw its largest daily ETF inflow in over a year. This rebound follows weeks of volatility and coincides with a ...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.